Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Culturally Aware CareWomen's HealthType 2 DiabetesChildren & TeensIssue 729

Maternal Diabetes Increases Risk for Type 2 Diabetes Children

Exposure to diabetes in utero may significantly impair beta-cell function in children.... 

Advertisement

Steven D. Chernausek, MD, associate chief of the pediatric diabetes and endocrinology section, the University of Oklahoma College of Medicine stated that, "We found that if the child is born to a mother with diagnosis either before or during the pregnancy, that child presented at a younger age with a diagnosis of diabetes, had measurable deterioration in glucose control, higher blood glucose on oral glucose tolerance tests, had higher HbA1c, and that this was all due to an effect on beta-cell function, not on insulin sensitivity."

"What we found was that the impact of the mother's diabetes on the beta cell was only apparent in non-Hispanic blacks and Hispanics. It wasn't apparent in Caucasians, and that was a surprising finding."

The TODAY study, a large well-controlled study looking at young, well-controlled adolescents with diabetes, was used in this analysis to look specifically at the effect on those patients born to women with diabetes in pregnancy.

Children born to mothers with diabetes had higher HbA1c and fasting blood glucose at baseline (P<.0001), and C-peptide index and oral disposition index, both of which were used as measures of beta-cell function, were decreased (P≤.0001). Pair-wise comparisons showed these effects were only present in non-Hispanic black and Hispanic participants (all P<.01).

Chernausek added that, "We've known for a long time there's differences in diabetes in Caucasians compared to Hispanics; there are differences of metabolic control." "This is another sign that type 2 diabetes is different in the Hispanic, non-Hispanic black populations. It manifests in different ways and they're susceptible to different things."

Practice Pearls:
  • Type 2 diabetes in utero significantly impairs beta-cell function in children.
  • The results of this study are preliminary and no conclusions should be made until it has been reviewed and published.
  • Type 2 diabetes is different in the Hispanic, non-Hispanic black populations.

Presented at: the Pediatric Academic Societies and Asian Society for Pediatric Research joint meeting; May 3-6, 2014; Vancouver, British Columbia. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  Culturally Aware CareWomen's HealthType 2 DiabetesChildren & TeensIssue 729

Past five issues: Diabetes Clinical Mastery Series Issue 208 | Issue 748 | GLP-1 Special Editions September 2014 | Diabetes Clinical Mastery Series Issue 207 | Issue 747 |

2014 Most Popular Articles:

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
FDA Approves Bupropion/Naltrexone (Contrave) for Obesity by Orexigen Therapeutics
Posted September 12, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014
An Exclusive Interview with Al Mann, Founder and CEO, Mannkind Corp.
Posted September 15, 2014
Sleeve Gastrectomy Now a Common Choice for Bariatric Surgery
Posted September 12, 2014
Type 2 Diabetes Diagnosis Needs to Be Changed: Prediabetes=Diabetes
Posted September 12, 2014
High-salt Diet and High HBA1c May Increase Cardiovascular Disease
Posted September 19, 2014
Predicting Which Diabetics Will Develop Major Complications
Posted September 05, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Now that once-weekly dulaglutide has been approved, will you be prescribing it?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control